Freestone Capital Holdings’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,953
| Closed | -$205K | – | 441 |
|
|
2024
Q4 | $205K | Hold |
11,953
| – | – | 0.01% | 419 |
|
|
2024
Q3 | $239K | Hold |
11,953
| – | – | 0.01% | 384 |
|
|
2024
Q2 | $134K | Hold |
11,953
| – | – | ﹤0.01% | 437 |
|
|
2024
Q1 | $78.9K | Hold |
11,953
| – | – | ﹤0.01% | 428 |
|
|
2023
Q4 | $54K | Hold |
11,953
| – | – | ﹤0.01% | 385 |
|
|
2023
Q3 | $42.8K | Hold |
11,953
| – | – | ﹤0.01% | 361 |
|
|
2023
Q2 | $44.1K | Hold |
11,953
| – | – | ﹤0.01% | 377 |
|
|
2023
Q1 | $39.6K | Hold |
11,953
| – | – | ﹤0.01% | 358 |
|
|
2022
Q4 | $46.4K | Hold |
11,953
| – | – | ﹤0.01% | 361 |
|
|
2022
Q3 | $29K | Hold |
11,953
| – | – | ﹤0.01% | 368 |
|
|
2022
Q2 | $24K | Buy |
+11,953
| New | +$24K | ﹤0.01% | 415 |
|